person

Johanna M.

Country
Finland
Department
Oncology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
3
Sites with multiple studies

Has run more than one trial at 3 of 91 partner sites.

Specializations

Breast Cancer Treatment

The investigator specializes in the treatment of HER2-positive breast cancer, with particular emphasis on advanced therapeutic approaches for both early-stage and metastatic disease.

  • Early-stage breast cancer management
  • Advanced and metastatic breast cancer treatment
  • HER2-targeted therapies

Their research focuses on innovative combination therapies involving targeted therapeutic agents including pertuzumab and trastuzumab for breast cancer treatment.

Therapeutic Innovation

The investigator explores novel therapeutic combinations in breast cancer treatment, evaluating the effectiveness of multiple targeted agents used simultaneously.

  • Combination therapy approaches
  • Treatment optimization strategies
  • Disease progression assessment

Their work includes evaluation of treatment efficacy in unresectable locally-advanced breast cancer cases.

Clinical Outcomes

The investigator's research encompasses the study of disease-free survival and progression-free survival in breast cancer patients.

  • Treatment response evaluation
  • Long-term outcome assessment
  • Therapeutic efficacy monitoring

Their work involves systematic evaluation of patient responses using established clinical assessment criteria.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.